We are The Machine Learning Immunology Company
Integration is at Our Epicenter
At Seismic Therapeutic™, we believe our unique approach to applying machine learning to biologics drug discovery will create positive change in the autoimmune landscape and the lives of patients.
PipelinePlatform
Hyper-Collaboration Fuels Our Focus
Just like our approach, we are a synthesis of many things. Keenly focused and spirited, yet curious and relentless – we are open to the possibilities of the new and the uncharted. We fully believe that our impact on the drug discovery paradigm directly correlates to our willingness to embrace inclusivity and collaboration.
See what’s happening at Seismic Therapeutic™ with our latest news and events.
April 12, 2024
Seismic Therapeutic Presents Preclinical Data on S-1117, its Novel Pan-IgG Protease Addressing Multiple Pathogenic Mechanisms in Autoimmune Disease, at American Academy of Neurology (AAN) 2024
Read more
April 9, 2024
Seismic Therapeutic Announces Participation at Multiple Upcoming Scientific Conferences in April and May 2024
Read more
March 8, 2024
Seismic Therapeutic to Present Preclinical Data for Novel Immunoglobulin Sculpting Enzyme at AAN Annual Meeting
Read more